Abstract
Cancer surveillance is entering an exciting era where the scope of its activities will be expanded and the amount, quality, and depth of information on cancer will be richer and more readily available to practitioners, decision makers and the public. This future is being built on a solid history of accomplishment that has placed cancer foremost among all chronic diseases in the organization and implementation of a systematic and integrated monitoring enterprise that is of essential value in both clinical medicine and public health. The future of cancer surveillance will be driven not only by innovations in methods of cancer surveillance itself, but also by developments in information technology and communication and by revolutionary new tools used in the delivery of medical care. At the same time, it will be a challenge to ensure levels of privacy and confidentiality needed to maintain the public trust. In the Cancer Surveillance and Information Summit, a 2004 conference sponsored by C-Change, experts from the field and from allied and related disciplines in both the public and private sectors met to consider the future of the cancer surveillance enterprise. Seven recommendations, detailed in this article, emerged from the conference to guide future growth and development. Steps that can and should be taken by all individuals and groups involved in cancer surveillance were included. The shared view is that cancer surveillance and information is essential to fulfill a vision for a future where cancer is prevented, detected early, and either cured or managed successfully as a chronic illness.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Notes
C-Change is a non-profit and multi-sector national cancer collaborative that collectively strives to address issues related to the full continuum of cancer care and control. [http://www.c-changetogether.org/].
References
Cancer surveillance futures project. April 2001. http://www.ndoc.org/about_ndc/reports/surveillance.asp
Cancer surveillance research implementation plan. Surveillance Implementation Group, National Cancer Institute, National Institutes of Health, March 1999. http://cancercontrol.cancer.gov/sig/ Accessed January 22, 2005
C-Change: collaborating to conquer cancer. (formerly the National Dialogue on Cancer) (http://www.ndoc.org/default.asp). Accessed January 22 2005
Comprehensive cancer control planning. Centers for Disease Control and Prevention (http://www.cdc.gov/cancer/ncccp/toolkit/index.htm)
Deapen D (2005) Impact of privacy and confidentiality concerns. a report from the cancer surveillance and information summit. Cancer Causes Control (under review)
Detmer DE (2003) Building the national health information infrastructure for personal health, health care services, public health, and research. BMC Med Inform Decis Mak 3:1
Gostin LO, Hodge JG Jr, Valdieserri RO (2001) Informational privacy and the public’s health: the model state public health privacy act. Am J Pub Health 91:1388–1392
Guide to community preventive services. CDC. http://www.cdc.gov/programs/partners4.htm
Hiatt RA (2003) HIPAA: The end of epidemiology, or a new social contract? (Commentary). Epidemiology 14:637–639
Hiatt RA, Rimer BK (1999) A new strategy for cancer control research. Cancer Epidemiol Biomarkers Prev 11:957–964
Howe HL, Edwards BK, Young JL, Shen T, West DW, Hutton M, Correa CN (2003) A vision for cancer incidence surveillance in the United States. Cancer Causes Control 14:663–672
Jemal A, Clegg LX, Ward E, Ries LAG, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101(1)
Shortliffe EH (2005) The informatics infrastructure: anticipating its role in cancer surveillance. Cancer Causes Control (under review)
Sittig DF (2005) Potential impact of advanced clinical information technology on cancer care in 2015. A report from the cancer surveillance and information summit. Cancer Causes Control (under review)
Swan J, Wingo P, Clive R, West D, Miller D, Hutchison C, Sondik EJ, Edwards BK (1998) Cancer surveillance in the U.S.: can we have a national system? Cancer 83(7):1282–1291
The cancer control PLANET (plan, link, act network with evidence-based tools). (http://cancercontrolplanet.cancer.gov/)
Wingo PA, Howe HL, Thun MJ, Ballard-Barbash R, Ward E, Brown ML, Sylvester J, Friedell GH, Alley L, Rowland JH, Edwards BK (2005) A national framework for cancer surveillance in the United States. Cancer Causes Control 16:151–170
Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M, Lee NC. Hall HI (2003) Building the infrastructure for nationwide cancer surveillance and control – a comparison between The National Program of Cancer Registries (NPCR) and The Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14:175–193
United States cancer statistics. 1999–2001 incidence and mortality: web-based report version. U.S. Cancer Statistics Working Group. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2004. Available at: www.cdc.gov/cancer/npcr/uscs. Accessed January 22, 2005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hiatt, R.A. The Future of Cancer Surveillance. Cancer Causes Control 17, 639–646 (2006). https://doi.org/10.1007/s10552-006-0003-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-006-0003-0